Furthermore, pregravid obesity is associated with transcriptional changes in genes that regulate inflammation, lipid metabolism, insulin resistance, angiogenesis, and hormone activity in the placenta (Saben et al., 2014a,b). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.